SEC Form 4 · Updated Daily
RCKT
— ROCKET PHARMACEUTICALS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | 10%+ Owner · Director | 19,188,457 | 2025-09-19 | X |
| Yalamanchi Naveen | Director | 16,272,635 | 2021-08-27 | A |
| Kantesaria Devang | 10%+ Owner | 3,253,566 | 2015-07-14 | M |
| LESCHLY MARK | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| KAIROUZ HABIB | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RUCH JOSHUA | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RHO VENTURES IV QP LP | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RHO VENTURES IV GMBH & CO BETEILIGUNGS KG | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RHO VENTURES IV LP | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RHO MANAGEMENT VENTURES IV LLC | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| RHO CAPITAL PARTNERS VERWALTUNGS GMBH | 10%+ Owner | 2,870,584 | 2015-02-23 | P |
| KARABELAS ARGERIS N | Director | 2,277,139 | 2015-02-23 | P |
| CARE CAPITAL INVESTMENTS II LP | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| Care Capital III LLC | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| Care Capital Offshore Investments II LP | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| CARE CAPITAL II LLC | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| Care Capital Investments III L.P. | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| Care Capital Offshore Investments III LP | 10%+ Owner | 2,277,139 | 2015-02-23 | P |
| MedImmune Ventures, Inc. | 10%+ Owner | 1,917,906 | 2015-02-23 | P |
| Pitango Venture Capital Principals Fund IV, L.P. | Reporting Owner | 1,292,584 | 2015-02-23 | P |
| Pitango Venture Capital Fund IV, L.P. | Reporting Owner | 1,292,584 | 2015-02-23 | P |
| Pitango V.C. Fund IV, L.P. | 10%+ Owner | 1,292,584 | 2015-02-23 | P |
| Pitango G.C. Capital Holdings Ltd. | 10%+ Owner | 1,292,584 | 2015-02-23 | P |
| Shah Gaurav | Director · Officer | 1,056,594 | 2026-08-18 | S |
| Rho Ventures IV-A, L.P. | 10%+ Owner | 636,496 | 2015-11-16 | J |
| Rho Ventures IV Holdings LLC | 10%+ Owner | 636,496 | 2015-11-16 | J |
| Wilson Martin | Officer | 598,489 | 2026-09-11 | S |
| Stevens Christopher James | Officer | 505,784 | 2026-08-11 | S |
| Patel Kinnari | Officer | 441,927 | 2025-05-20 | S |
| Makker Gotham | Director | 415,346 | 2025-06-18 | A |
| Rizvi Syed Ali-aamir | Officer | 407,874 | 2026-02-11 | A |
| Schwartz Jonathan David | Officer | 299,064 | 2025-11-18 | S |
| Chaudhuri Sarbani | Officer | 262,809 | 2026-08-11 | S |
| SOUTHWELL DAVID P | Director | 204,522 | 2026-08-03 | J |
| Ondrey Aaron | Officer | 128,173 | 2025-07-03 | S |
| Militello John | Officer | 89,780 | 2026-05-19 | S |
| Fong Peter | Director | 76,195 | 2026-06-18 | A |
| WONG RODERICK | 10%+ Owner · Director | 75,499 | 2026-06-18 | A |
| White Mark Andrew | Officer | 69,140 | 2024-10-31 | S |
| Dolsten Mikael | Director | 67,082 | 2026-06-18 | A |
| GRANADILLO PEDRO P | Director | 54,734 | 2025-06-18 | A |
| Malik Fady Ibraham | Officer | 52,862 | 2026-06-18 | A |
| BOESS CARSTEN | Director | 52,862 | 2026-06-18 | A |
| Manhede Joseph | Officer | 52,576 | 2026-07-08 | — |
| Bjork Elisabeth | Director | 50,000 | 2026-01-02 | P |
| Pratumsuwan Piratip | Director | 30,000 | 2025-06-18 | A |
| RITTER DALE | Officer | 19,827 | 2017-09-14 | M |
| CARROLL J MARTIN | Director | 10,000 | 2016-05-13 | P |
| Devon Park Associates, L.P. | 10%+ Owner | 9,857 | 2017-01-04 | J |
| Devon Park Associates, LLC | 10%+ Owner | 9,857 | 2017-01-04 | J |
| DEVON PARK BIOVENTURES LP | 10%+ Owner | 9,857 | 2017-01-04 | J |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-11 | Wilson Martin | Open-market sale | 75,364 | $3.40 | 598,489 |
| 2026-08-18 | Shah Gaurav | Open-market sale | 2,293 | $3.38 | 1,056,594 |
| 2026-08-18 | Wilson Martin | Open-market sale | 631 | $3.38 | 673,853 |
| 2026-08-13 | Wilson Martin | Open-market sale | 3,493 | $3.38 | 674,484 |
| 2026-08-13 | Shah Gaurav | Open-market sale | 2,837 | $3.38 | 1,058,887 |
| 2026-08-11 | Chaudhuri Sarbani | Open-market sale | 4,701 | $3.50 | 262,809 |
| 2026-08-11 | Stevens Christopher James | Open-market sale | 36,658 | $3.50 | 505,784 |
| 2026-08-03 | SOUTHWELL DAVID P | J | 150,000 | $0.00 | 204,522 |
| 2026-08-03 | Stevens Christopher James | Grant / award (derivative) | 101,428 | $0.00 | 101,428 |
| 2026-08-03 | Stevens Christopher James | Grant / award | 73,313 | $0.00 | 542,442 |
| 2026-07-08 | Manhede Joseph | — | — | — | 52,576 |
| 2026-06-18 | BOESS CARSTEN | Grant / award (derivative) | 64,860 | $0.00 | 64,860 |
| 2026-06-18 | BOESS CARSTEN | Grant / award | 22,862 | $0.00 | 52,862 |
| 2026-06-18 | SOUTHWELL DAVID P | Grant / award (derivative) | 64,860 | $0.00 | 64,860 |
| 2026-06-18 | SOUTHWELL DAVID P | Grant / award | 22,862 | $0.00 | 54,522 |
| 2026-06-18 | Malik Fady Ibraham | Grant / award (derivative) | 64,860 | $0.00 | 64,860 |
| 2026-06-18 | Malik Fady Ibraham | Grant / award | 22,862 | $0.00 | 52,862 |
| 2026-06-18 | Dolsten Mikael | Grant / award (derivative) | 64,860 | $0.00 | 64,860 |
| 2026-06-18 | Dolsten Mikael | Grant / award | 22,862 | $0.00 | 67,082 |
| 2026-06-18 | Fong Peter | Grant / award (derivative) | 64,860 | $0.00 | 64,860 |
| 2026-06-18 | Fong Peter | Grant / award | 22,862 | $0.00 | 76,195 |
| 2026-06-18 | WONG RODERICK | Grant / award (derivative) | 78,960 | $0.00 | 78,960 |
| 2026-06-18 | WONG RODERICK | Grant / award | 27,832 | $0.00 | 75,499 |
| 2026-05-26 | Militello John | Grant / award (derivative) | 9,091 | — | 9,091 |
| 2026-05-26 | Militello John | Grant / award (derivative) | 24,899 | — | 24,899 |
| 2026-05-26 | Militello John | Grant / award (derivative) | 16,061 | — | 16,061 |
| 2026-05-26 | Militello John | Grant / award (derivative) | 15,002 | — | 15,002 |
| 2026-05-26 | Militello John | Grant / award (derivative) | 51,509 | — | 51,509 |
| 2026-05-26 | Militello John | Disposition to issuer (derivative) | 10,000 | — | 0 |
| 2026-05-21 | Shah Gaurav | Option exercise (derivative) | 76,490 | $1.69 | 0 |
| 2026-05-21 | Shah Gaurav | Open-market sale | 55,684 | $3.09 | 1,061,724 |
| 2026-05-21 | Shah Gaurav | Option exercise | 76,490 | $1.69 | 1,117,408 |
| 2026-05-19 | Militello John | Open-market sale | 384 | $3.01 | 89,780 |
| 2026-05-19 | Wilson Martin | Open-market sale | 662 | $3.01 | 677,977 |
| 2026-05-19 | Shah Gaurav | Open-market sale | 2,409 | $3.01 | 1,040,918 |
| 2026-05-13 | Militello John | Open-market sale | 855 | $3.61 | 90,164 |
| 2026-05-13 | Shah Gaurav | Open-market sale | 2,728 | $3.61 | 1,043,327 |
| 2026-05-13 | Wilson Martin | Open-market sale | 3,361 | $3.61 | 678,639 |
| 2026-05-07 | Chaudhuri Sarbani | Open-market sale | 17,650 | $3.84 | 267,510 |
| 2026-02-18 | Wilson Martin | Open-market sale | 1,376 | $3.34 | 682,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.